Singaporean startup Aevice Health has received approval from Australia's Therapeutic Goods Administration for the use of its AI-powered respiratory monitoring system in individuals aged 3 and above.
The stethoscope, long revered as an essential instrument in patient diagnosis and care, is increasingly being scrutinised for its role as a potential vector in the transmission of infectious agents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback